FDA Registration
Active
🇨🇦 Canada
LUMINEX MOLECULAR DIAGNOSTICS, INC.
Reg #: 3002777243
·
FEI: 3002777243
·
Expires 2026
Products
16
Proprietary Names
17
Establishment Types
1
Classifications
16
Registration Details
- Registration Name
- LUMINEX MOLECULAR DIAGNOSTICS, INC.
- Registration Number
- 3002777243
- FEI Number
- 3002777243
- Status
- Active
- Expiry Year
- 2026
- Initial Importer
- No
- Address
- 439 UNIVERSITY AVE.
- City
- TORONTO Ontario
- Country
- CA
Regulatory Submissions
- 510(k) Number
- K231758
Owner / Operator
- Firm Name
- Luminex Corporation
- Operator Number
- 9032042
- Address
- 12212 Technology Blvd.
- City
- Austin
- State
- TX
- Postal Code
- 78727
- Country
- US
- Correspondent
- Mari Meyer
US Agent
- Business Name
- LUMINEX CORP.
- Contact Name
- Mari Meyer
- Address
- 12212 TECHNOLOGY BLVD.
- City
- AUSTIN
- State
- TX
- ZIP
- 78727
- Country
- US
- [email protected]
- Phone
- 715 4107149 ext. 0
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | QOF | Class 2 | Microbiology | No | 2024-05-15 |
| System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection | NUA | Class 2 | Immunology | No | 2017-02-03 |
| Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System | PCH | Class 2 | Microbiology | No | 2013-05-13 |
| Respiratory Virus Panel Nucleic Acid Assay System | OCC | Class 2 | Microbiology | No | 2008-02-01 |
| Clinical Sample Concentrator | JJH | Class 1 | Clinical Chemistry | No | 2013-05-13 |
| Instrumentation For Clinical Multiplex Test Systems | NSU | Class 2 | Clinical Chemistry | No | 2013-05-13 |
| Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna | NXD | Class 2 | Microbiology | No | 2024-11-26 |
| Parainfluenza Multiplex Nucleic Acid Assay | OOU | Class 2 | Microbiology | No | 2024-11-26 |
| Non-Sars Coronavirus Multiplex Nucleic Acid Assay | OTG | Class 2 | Microbiology | No | 2024-11-26 |
| Chlamydophila Pneumoniae Dna Assay System | OZY | Class 2 | Microbiology | No | 2024-11-26 |
| Human Metapneumovirus (Hmpv) Rna Assay System | OEM | Class 2 | Microbiology | No | 2024-11-26 |
| Real Time Nucleic Acid Amplification System | OOI | Class 2 | Clinical Chemistry | No | 2024-11-26 |
| Mycoplasma Pneumoniae Dna Assay System | OZX | Class 2 | Microbiology | No | 2024-11-26 |
| Influenza A Virus Subtype Differentiation Nucleic Acid Assay | OEP | Class 2 | Microbiology | No | 2024-11-26 |
| General Purpose Reagent | PPM | Class 1 | Pathology | No | 2004-04-09 |
| Drug Metabolizing Enzyme Genotyping Systems | NTI | Class 2 | Clinical Toxicology | No | 2013-11-01 |
Proprietary Names
NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2)
Xtag Cystic Fibrosis 60 Kit V2
Gastrointestinal Pathogen Panel (GPP)
xTAG Respiratory Viral Panel
xTAG Cystic Fibrosis 39 kit v2
NXTAG Respiratory Pathogen Panel
xTAG Gastrointestinal Pathogen Panel
xTAG GPP
Xtag Cystic Fibrosis 39 Kit V2
NxTAG® Respiratory Pathogen Panel
xTAG® Gastrointestinal Pathogen Panel (GPP)
xTAG® Data Analysis Software (TDAS GPP)
xTAG
TAG-IT
xTAG CYP2C19 KIT V3
NxTAG Respiratory Pathogen Panel
xTAG Cystic Fibrosis 60 kit v2
Establishment Types
Manufacture Medical Device